Overview

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

Status:
Completed
Trial end date:
2004-04-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find the optimal dose of Org 37462 for Japanese females undergoing controlled ovarian stimulation for in vitro fertilization intracytoplasmic sperm injection (IVF-ICSI).
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ganirelix